Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IOBENGUANE I-131 vs IOMEPROL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IOBENGUANE I-131 vs IOMEPROL: Safety Overview

Metric IOBENGUANE I-131 IOMEPROL
Total FAERS Reports 123 1,121
Deaths Reported 13 86
Death Rate 10.6% 7.7%
Hospitalizations 25 713
Average Patient Age 22.3 yrs 61.5 yrs
% Female Patients 50.0% 49.1%
FDA Approval Date Jul 30, 2018 Nov 27, 2024
Manufacturer N/A BIPSO GmbH
Route N/A INTRA-ARTERIAL
Marketing Status Discontinued Discontinued